NLE Reproductive Health & Family Planning — Reproductive Anatomy, Physiology & the Menstrual CycleDetailed Explanation

The Male Reproductive System: Structures and Functions

The male reproductive system serves four main functions: production of sperm (spermatogenesis), maturation and storage of sperm, secretion of testosterone, and delivery of sperm during ejaculation. Each structure plays a specific role in this sequence. The TESTES are the primary male gonads, housed inside the SCROTUM. The scrotum maintains testicular temperature at approximately 1–2°C BELOW core body temperature (~35–36°C), a condition essential for normal spermatogenesis. Inside the testes, the SEMINIFEROUS TUBULES are where sperm are produced. Surrounding these tubules are the LEYDIG (INTERSTITIAL) CELLS, which produce TESTOSTERONE under stimulation from LH from the anterior pituitary. SERTOLI CELLS within the seminiferous tubules support, nourish, and coordinate sperm development under FSH stimulation. After production, immature sperm travel to the EPIDIDYMIS, a tightly coiled tube where they MATURE and acquire MOTILITY over approximately 2–3 weeks. Mature sperm are stored in the tail of the epididymis. During ejaculation, sperm travel through the VAS DEFERENS (ductus deferens), pass the EJACULATORY DUCT, and exit through the URETHRA. The VAS DEFERENS is the structure severed in a VASECTOMY, the male permanent contraceptive method. Three accessory glands contribute to semen: 1. SEMINAL VESICLES — secrete a fructose-rich, alkaline fluid that provides energy for sperm (makes up ~60% of semen volume). 2. PROSTATE GLAND — secretes a thin, alkaline, milky fluid that neutralizes vaginal acidity and enhances sperm motility; surrounds the urethra (important clinically — benign prostatic hyperplasia compresses the urethra). 3. BULBOURETHRAL (COWPER'S) GLANDS — secrete pre-ejaculatory mucus that cleans and lubricates the urethra before ejaculation. A reflex CLOSES THE BLADDER NECK during ejaculation, ensuring that urine and semen do not pass simultaneously through the urethra. SPERMATOGENESIS takes approximately 64–74 days from start to finish. A normal semen analysis (WHO criteria) shows: volume 2–5 mL, concentration ≥15 million sperm/mL, progressive motility ≥32%, and normal morphology ≥4%. Each sperm carries either an X or a Y chromosome — the FATHER determines the biological sex of the child (XX = female, XY = male).

The Female Reproductive System: External and Internal Anatomy

The female reproductive system includes both external structures (collectively called the VULVA) and internal organs. Together they support the production of ova, provide the environment for fertilization and fetal development, and serve as the birth canal. EXTERNAL GENITALIA (VULVA): - MONS PUBIS: A pad of fatty tissue over the pubic symphysis; covered with pubic hair after puberty. - LABIA MAJORA: Two large, fatty folds; outer protective structure; homologous to the scrotum in the male. - LABIA MINORA: Two thinner, hairless inner folds; highly vascular and sensitive; converge anteriorly to form the prepuce of the clitoris. - CLITORIS: Small erectile, highly sensory organ at the anterior junction of the labia minora; homologous to the penis. - VESTIBULE: The space between the labia minora containing the urethral meatus anteriorly and the vaginal opening (introitus) posteriorly. - BARTHOLIN'S GLANDS (greater vestibular glands): Located at the 4 o'clock and 8 o'clock positions of the vaginal opening; secrete mucus for lubrication during arousal. BARTHOLIN'S CYST is a common complication when the duct becomes blocked. - PERINEUM: The anatomical area between the vaginal opening and the anus; the site of EPISIOTOMY (surgical incision to enlarge the vaginal outlet during delivery) and perineal lacerations. INTERNAL ORGANS: 1. VAGINA: A fibromuscular canal, 8–10 cm long, serving as the birth canal, the passageway for menstrual flow, and the organ of copulation. The vaginal environment is normally ACIDIC (pH 3.5–4.5) due to DÖDERLEIN'S LACTOBACILLI, which convert glycogen to lactic acid. This acidity protects against pathogens. Anything that disrupts this flora (antibiotics, douching) predisposes to infection (e.g., candidiasis). 2. UTERUS: A hollow, pear-shaped, muscular organ about 7–8 cm long in the non-pregnant state. It has three anatomical parts: - FUNDUS: The domed upper portion above the fallopian tube insertions; PALPATED to estimate gestational age (fundal height in cm ≈ weeks of gestation from 20–36 weeks) and postpartum involution. - BODY (CORPUS): The main portion. - CERVIX: The lower cylindrical neck opening into the vagina via the EXTERNAL OS (visible on speculum exam) and the INTERNAL OS. The ENDOCERVICAL CANAL connects these. The cervix softens, effaces, and dilates during labor. The uterus has three tissue layers: - PERIMETRIUM: Outer serosal (peritoneal) covering. - MYOMETRIUM: Thick middle smooth muscle layer — generates contractions during labor and CLAMPS blood vessels postpartum to prevent hemorrhage. The myometrium is the target of oxytocin. Fibroids (leiomyomas) arise from the myometrium. - ENDOMETRIUM: Inner mucosal lining; the FUNCTIONAL LAYER sheds during menstruation and where IMPLANTATION of the blastocyst occurs. The BASAL LAYER remains after menstruation to regenerate the functional layer. Normal uterine position: ANTEVERTED (uterus tilts forward over the bladder) and ANTEFLEXED (body of uterus bends forward at the cervix). A retroverted uterus may be associated with dysmenorrhea and difficulty with some intrauterine procedures. 3. FALLOPIAN (UTERINE) TUBES: Two tubes, each approximately 10 cm long, extending from the uterine cornua to near the ovaries. Four segments: - INTERSTITIAL (intramural): Passes through the uterine wall. - ISTHMUS: Narrow medial segment; site of TUBAL LIGATION (permanent female contraception). - AMPULLA: The widest, longest segment; SITE OF NORMAL FERTILIZATION — this is the single most high-yield fact about the fallopian tubes in the NLE. - INFUNDIBULUM: Funnel-shaped distal end with finger-like FIMBRIAE that sweep the released ovum into the tube. CILIA lining the tube and PERISTALTIC contractions move the fertilized ovum toward the uterus (takes ~3–4 days). ECTOPIC PREGNANCY most commonly occurs in the fallopian tube (tubal ectopic), usually in the AMPULLA, when transport is impaired (e.g., by pelvic inflammatory disease, previous tubal surgery). 4. OVARIES: Two almond-shaped gonads, each about 3–4 cm long in the reproductive years. Functions: - Store OOCYTES in various stages of follicular development. - Release one mature ovum per cycle (OVULATION). - Secrete OESTROGEN (mainly from follicular granulosa cells) and PROGESTERONE (from the corpus luteum after ovulation). A woman is born with approximately 1–2 million oocytes. At puberty, approximately 400,000 remain. Over a lifetime, only about 400 will mature and ovulate. After each cycle, many follicles that began developing undergo ATRESIA (degeneration). THE BONY PELVIS (OBSTETRIC RELEVANCE): The TRUE (LESSER) PELVIS, bounded above by the pelvic inlet (linea terminalis) and below by the pelvic outlet, is the actual BIRTH CANAL through which the fetus passes. FOUR PELVIC TYPES (Caldwell-Moloy classification): - GYNECOID: Round inlet (~50% of women) — MOST FAVORABLE for vaginal delivery. - ANDROID: Heart-shaped (male-type) — associated with difficult labor, instrument delivery. - ANTHROPOID: Oval (anterior-posterior diameter wider) — usually allows vaginal delivery. - PLATYPELLOID: Flat, wide transverse — most difficult for labor. Clinically important measurements: - DIAGONAL CONJUGATE (DC): Measured clinically from the lower border of the pubic symphysis to the sacral promontory; normally ≥12.5 cm. - TRUE (OBSTETRIC) CONJUGATE: The shortest diameter of the pelvic inlet (anteroposterior); estimated as DC minus 1.5 cm; should be ≥11 cm. This is the critical measurement for fetal head passage. - A contracted pelvis (obstetric conjugate <10 cm) predisposes to CEPHALOPELVIC DISPROPORTION (CPD).

Reproductive Hormones: The HPO Axis and Key Hormones

Reproductive function in both sexes is governed by a hormonal feedback system known as the HYPOTHALAMIC-PITUITARY-GONADAL (HPG) AXIS — in females, specifically the HYPOTHALAMIC-PITUITARY-OVARIAN (HPO) AXIS. Understanding this axis is essential for understanding the menstrual cycle, contraceptive mechanisms, and the basis of hormonal disorders. THE HPO AXIS — HOW IT WORKS: 1. HYPOTHALAMUS → releases GNRH (Gonadotropin-Releasing Hormone) in pulses. 2. ANTERIOR PITUITARY → GnRH stimulates the release of FSH and LH. 3. OVARIES → FSH and LH stimulate follicular development and hormone production. 4. FEEDBACK LOOPS: Ovarian hormones (oestrogen and progesterone) feed back to the hypothalamus and pituitary to modulate GnRH, FSH, and LH secretion. KEY HORMONES IN DETAIL: 1. GnRH (Gonadotropin-Releasing Hormone) - Source: HYPOTHALAMUS - Function: Stimulates anterior pituitary to release FSH and LH. - Clinical use: GnRH agonists (e.g., leuprolide) used in treating endometriosis, uterine fibroids, and in IVF protocols. 2. FSH (Follicle-Stimulating Hormone) - Source: ANTERIOR PITUITARY (gonadotroph cells) - FEMALE function: Stimulates growth and maturation of ovarian follicles (recruits multiple follicles at the start of the cycle). - MALE function: Acts on SERTOLI CELLS to support spermatogenesis. - Elevated FSH is an early marker of DIMINISHED OVARIAN RESERVE (perimenopause). 3. LH (Luteinizing Hormone) - Source: ANTERIOR PITUITARY - FEMALE function: The MIDCYCLE LH SURGE (triggered by high oestrogen via positive feedback) is the direct trigger of OVULATION. After ovulation, LH maintains the corpus luteum. - MALE function: Stimulates LEYDIG CELLS to produce TESTOSTERONE. - LH urine tests (ovulation predictor kits / OPKs) detect the LH surge 24–36 hours before ovulation — used in fertility awareness. 4. OESTROGEN (primarily ESTRADIOL, E2) - Sources: Follicular GRANULOSA CELLS (mainly), adrenal cortex, adipose tissue, and placenta during pregnancy. - Functions: a. Stimulates ENDOMETRIAL PROLIFERATION (thickening of the uterine lining). b. Stimulates development of SECONDARY SEX CHARACTERISTICS (breast development, female fat distribution, pubic hair). c. Produces THIN, CLEAR, STRETCHY, SLIPPERY CERVICAL MUCUS at ovulation (called SPINNBARKEIT — 'spin' means the mucus can be stretched to 8–10 cm without breaking, resembling raw egg white). This mucus is SPERM-FRIENDLY. d. Rising oestrogen in the late follicular phase triggers a POSITIVE FEEDBACK on the anterior pituitary → LH SURGE → OVULATION. e. Negative feedback on FSH and LH at lower levels (keeps multiple follicles from maturing simultaneously). f. Promotes bone density and favorable lipid profile. - Clinical correlation: Combined oral contraceptives (COCs) contain synthetic oestrogen — they suppress FSH (preventing follicle development) and create thick, hostile cervical mucus. 5. PROGESTERONE - Source: CORPUS LUTEUM after ovulation; PLACENTA after week 10 of pregnancy; adrenal cortex (small amounts). - Nicknamed: The 'HORMONE OF PREGNANCY' or 'Pro-gestation hormone.' - Functions: a. Converts the endometrium from proliferative to SECRETORY phase (nutrient-rich, glandular, ready for implantation). b. RAISES BASAL BODY TEMPERATURE by ~0.3–0.5°C after ovulation (thermogenic effect) — the basis of the BBT method of fertility awareness. c. Makes cervical mucus THICK, SCANTY, STICKY, and IMPENETRABLE to sperm (opposite of oestrogen's effect). d. RELAXES SMOOTH MUSCLE throughout the body (uterine quiescence during pregnancy; also causes GI slowing → constipation in pregnancy, and venous dilation). e. SUPPRESSES UTERINE CONTRACTIONS to maintain pregnancy. f. Maintains the corpus luteum (until hCG takes over). - Clinical correlation: Progesterone-only pills (mini-pills), Depo-Provera (DMPA), and the Mirena IUD work primarily by thickening cervical mucus and thinning the endometrium. 6. hCG (HUMAN CHORIONIC GONADOTROPIN) - Source: TROPHOBLAST cells of the developing embryo, then the PLACENTA after implantation. - Function: RESCUES THE CORPUS LUTEUM from degenerating at the end of the luteal phase, so progesterone continues to be produced to maintain the early pregnancy until the placenta takes over at about 10–12 weeks. - Detected by: Urine and serum PREGNANCY TESTS. Serum beta-hCG is the most sensitive and specific early pregnancy test. - Levels: Rise dramatically in early pregnancy, doubling approximately every 48–72 hours; peak at approximately 10–12 weeks, then decline. - Clinical correlation: Abnormally high hCG = suspect HYDATIDIFORM MOLE or multiple pregnancy. Abnormally low or slowly rising hCG = suspect ectopic pregnancy or threatened abortion. 7. TESTOSTERONE (in females) - Produced in small amounts by the ovaries and adrenal cortex. - Important for libido and energy. - Excess (e.g., in polycystic ovarian syndrome, PCOS) causes hirsutism, acne, and anovulation. FEEDBACK MECHANISMS SUMMARY: - LOW oestrogen → NEGATIVE FEEDBACK → stimulates FSH/LH (beginning of cycle, recruiting follicles). - HIGH oestrogen (pre-ovulatory peak) → POSITIVE FEEDBACK → LH SURGE → OVULATION. - HIGH progesterone + oestrogen (luteal phase) → NEGATIVE FEEDBACK → suppresses FSH/LH (prevents new cycle during luteal phase). - DROP in progesterone and oestrogen (corpus luteum demise) → RELEASES negative feedback → FSH rises → new cycle begins.

The Menstrual Cycle: Ovarian and Endometrial Phases

The menstrual cycle is a RECURRING, COORDINATED SERIES OF HORMONAL AND STRUCTURAL CHANGES in the ovary and uterus that prepare the body for pregnancy each month. It is controlled by the HPO axis and runs simultaneously on two parallel tracks: the OVARIAN CYCLE (what happens to the follicle and corpus luteum) and the ENDOMETRIAL (UTERINE) CYCLE (what happens to the uterine lining). BASIC CYCLE PARAMETERS: - Average length: 28 days (normal range: 21–35 days) - Day 1: First day of MENSTRUAL BLEEDING - Menstrual flow: 2–7 days - Normal blood loss: 30–80 mL per cycle (>80 mL = menorrhagia) - CRITICAL RULE: Cycle length variation comes from the FOLLICULAR PHASE; the LUTEAL PHASE is a CONSTANT ~14 days. ===== THE OVARIAN CYCLE ===== PHASE 1: FOLLICULAR PHASE (Days 1–13 in a 28-day cycle; VARIABLE LENGTH) - At the beginning of the cycle, FSH from the anterior pituitary rises (released from negative feedback inhibition when progesterone falls). - FSH recruits 10–20 primary follicles. Through a process of selection, one becomes dominant: the GRAAFIAN (DOMINANT) FOLLICLE. - The dominant follicle secretes increasing amounts of OESTROGEN. - Rising oestrogen → POSITIVE FEEDBACK on anterior pituitary → LH SURGE. - Phase ends at ovulation. PHASE 2: OVULATION (About Day 14 in a 28-day cycle) - The MIDCYCLE LH SURGE (occurring approximately 34–36 hours before follicle rupture) is the trigger. - The Graafian follicle RUPTURES, releasing the mature SECONDARY OOCYTE (technically not yet a fully mature ovum until fertilization is complete) into the peritoneal cavity. - The FIMBRIAE of the fallopian tube sweep the oocyte into the AMPULLA. - Some women experience MITTELSCHMERZ — mild, unilateral lower abdominal pain at ovulation, caused by follicular fluid/blood irritating the peritoneum. - Mid-cycle spotting (Zwischenblutung) may occur due to the transient drop in oestrogen just before the LH surge. - OVULATION FORMULA: In cycles other than 28 days, estimate ovulation as: CYCLE LENGTH − 14 DAYS. Example: 32-day cycle → ovulation occurs on Day 18 (32 − 14 = 18). PHASE 3: LUTEAL PHASE (Days 15–28; FIXED ~14 Days) - The ruptured follicle transforms (under LH influence) into the CORPUS LUTEUM ('yellow body'). - The corpus luteum secretes PROGESTERONE (primarily) and some oestrogen. - Progesterone acts on the endometrium, causing the secretory changes needed for implantation. - Progesterone also RAISES BBT by 0.3–0.5°C. - IF FERTILIZATION OCCURS: The developing embryo produces HCG, which RESCUES the corpus luteum → progesterone continues → no menstruation → pregnancy is maintained. - IF FERTILIZATION DOES NOT OCCUR: After 10–12 days, hCG is absent, the corpus luteum DEGENERATES into the CORPUS ALBICANS ('white body'), progesterone and oestrogen fall → endometrium sheds → MENSTRUATION begins → Day 1 of new cycle. ===== THE ENDOMETRIAL (UTERINE) CYCLE ===== PHASE 1: MENSTRUAL PHASE (Days 1–5) - TRIGGERED BY: Drop in progesterone and oestrogen (corpus luteum demise). - The FUNCTIONAL LAYER of the endometrium undergoes ischemic necrosis and is SHED as menstrual flow. - The BASAL LAYER remains and serves as the regeneration source. - The endometrium is at its THINNEST during this phase (about 1–2 mm). PHASE 2: PROLIFERATIVE PHASE (Days 6–14; coincides with follicular phase) - DRIVEN BY: Rising OESTROGEN from the growing follicle. - The endometrium REBUILDS and THICKENS (from ~1–2 mm to ~8–10 mm at ovulation). - Endometrial glands lengthen; blood supply increases. - Cervical mucus becomes increasingly thin, clear, and stretchy (SPINNBARKEIT) — this is the most fertile mucus sign. - Phase ends at OVULATION. PHASE 3: SECRETORY PHASE (Days 15–28; coincides with luteal phase) - DRIVEN BY: PROGESTERONE from the corpus luteum. - Endometrial glands become TORTUOUS and fill with GLYCOGEN-RICH SECRETIONS. - Endometrium becomes edematous and highly vascular — creating a LUSH, NUTRIENT-RICH environment for implantation. - Endometrium reaches maximum thickness (~10–14 mm). - Cervical mucus becomes THICK, STICKY, and OPAQUE — forms a CERVICAL MUCUS PLUG that prevents sperm entry. - BBT remains elevated. - If NO implantation: progesterone drops, endometrium degenerates, menstruation begins. SUMMARY TABLE (Key Parallel Phases): - Days 1–5: Menstrual phase (endometrium) / Follicular phase begins (ovary) / FSH rises - Days 6–13: Proliferative phase (endometrium) / Follicular phase (ovary) / Oestrogen rises - Day 14: Ovulation (ovary) / End of proliferative phase / LH surge - Days 15–28: Secretory phase (endometrium) / Luteal phase (ovary) / Progesterone dominant - Day 28+: Menstruation (if no pregnancy) / Corpus albicans formed / Cycle restarts

Signs of Ovulation, Fertility, and Conception

Understanding the SIGNS OF OVULATION and the MECHANICS OF CONCEPTION is essential for both family planning counseling and infertility assessment in clinical nursing practice. SIGNS OF OVULATION: Multiple physiological changes occur around ovulation that can be observed and tracked: 1. BASAL BODY TEMPERATURE (BBT): - BBT is the LOWEST RESTING BODY TEMPERATURE measured first thing in the morning before any activity (speaking, eating, rising from bed). - PATTERN: BBT shows a slight DIP just before ovulation, followed by a SUSTAINED RISE of 0.3–0.5°C (approximately 0.5°F) after ovulation. - This rise is caused by PROGESTERONE from the corpus luteum (thermogenic effect). - BBT REMAINS ELEVATED for the rest of the luteal phase (~12–14 days). - If PREGNANCY occurs, BBT stays elevated (progesterone from corpus luteum maintained by hCG). - If NO PREGNANCY: BBT drops as progesterone falls, and menstruation begins. - LIMITATION: BBT confirms PAST ovulation, not UPCOMING ovulation — it is retrospective. - HOW TO TEACH: Measure with a sensitive thermometer each morning at the same time, before getting out of bed; chart daily on a standardized form; look for the biphasic pattern. 2. CERVICAL MUCUS CHANGES (BILLINGS METHOD): - EARLY CYCLE (post-menstrual, pre-ovulatory): DRY or minimal, cloudy, sticky, thick, scant mucus. - APPROACHING OVULATION: Mucus becomes increasingly WET, CLEAR, SLIPPERY, STRETCHY. - PEAK FERTILE MUCUS (at ovulation): SPINNBARKEIT — clear like raw egg white, stretches 8–10 cm without breaking; most favourable for sperm passage and survival. - POST-OVULATION: Mucus returns to THICK, CLOUDY, STICKY (progesterone effect). - Spinnbarkeit is driven by OESTROGEN; thick mucus is driven by PROGESTERONE. 3. CERVICAL CHANGES: - At ovulation: The cervix rises higher in the vaginal vault, SOFTENS (from firm like a nose to soft like lips), OPENS slightly (external os opens), and becomes MORE MOIST. - Post-ovulation: Returns to firm, low, closed, dry (the '4 Ds': Down, Dry, Dimpled, Dense). - Mnemonic: SHOW — Soft, High, Open, Wet = fertile cervix. 4. MITTELSCHMERZ: - German for 'middle pain' — a mild, crampy or sharp unilateral lower abdominal pain occurring at the time of ovulation. - Caused by follicular fluid or a small amount of blood entering the peritoneal cavity after follicle rupture. - Typically lasts minutes to a few hours; benign. - May help women identify ovulation but is not reliable enough alone for family planning. 5. LH SURGE (detected by OPKs): - Urine LH tests (ovulation predictor kits) detect the surge about 24–36 hours before ovulation. - Most reliable biochemical predictor of impending ovulation. THE FERTILE WINDOW: - OVUM SURVIVAL: ~24 HOURS after ovulation. - SPERM SURVIVAL: ~48–72 hours in typical conditions; UP TO 5 DAYS in fertile (spinnbarkeit) cervical mucus. - FERTILE WINDOW: Approximately 5 DAYS BEFORE ovulation through 1 DAY AFTER ovulation = about a 6-day window. - IMPORTANT: A woman CAN conceive even if she has intercourse 5 days before ovulation, because sperm can wait in the fallopian tube. CONCEPTION SEQUENCE: 1. OVULATION: Mature oocyte released from Graafian follicle. 2. OVUM PICKUP: Fimbriae sweep the oocyte into the AMPULLA of the fallopian tube. 3. FERTILIZATION: One sperm (from hundreds of millions) penetrates the ovum in the AMPULLA. The ZONA PELLUCIDA undergoes the zona reaction to prevent polyspermy. The fertilized cell is the ZYGOTE (2n = 46 chromosomes: 23 from mother + 23 from father). 4. CLEAVAGE: The zygote begins rapid mitotic divisions (cleavage) as it travels down the fallopian tube. 5. MORULA: A solid ball of 16–32 cells, resembling a mulberry, formed about 3–4 days after fertilization. 6. BLASTOCYST: The morula develops a fluid-filled cavity (blastocoel), becoming a blastocyst. The INNER CELL MASS (embryoblast) will become the embryo; the OUTER LAYER (trophoblast) will become the placenta and membranes. 7. IMPLANTATION: The blastocyst reaches the uterus about 3–4 days after fertilization and implants into the SECRETORY ENDOMETRIUM about 6–10 DAYS AFTER FERTILIZATION (typically Days 20–24 of a 28-day cycle). 8. The trophoblast secretes hCG → maintains corpus luteum → progesterone continues → pregnancy is established. FERTILITY AND INFERTILITY: - INFERTILITY: Failure to conceive after 12 months of regular (2–3 times/week) unprotected intercourse. If the woman is OVER 35: evaluated after 6 months. - Approximately one-third of infertility cases are female factor (ovulatory disorders, tubal blockage, uterine anomalies); one-third are male factor (low count, motility, morphology); one-third are combined or unexplained. - FECUNDITY declines with maternal age, particularly after ~35 years, as oocyte quality and quantity diminish. - MENOPAUSE: Permanent cessation of menses, defined as 12 consecutive months without a menstrual period. Average age in the Philippines: ~51 years. Caused by depletion of ovarian follicles → no oestrogen → rising FSH and LH (removing negative feedback). PERIMENOPAUSE: The transitional years before menopause, characterized by irregular cycles, fluctuating hormones, and vasomotor symptoms (hot flushes, night sweats). NURSING ROLE IN FERTILITY EDUCATION: Under RA 9173 (Philippine Nursing Act of 2002) and RA 10354 (RPRH Act), nurses in public health settings are mandated to provide ACCURATE, OBJECTIVE, NON-COERCIVE family planning education. Nurses should: - Teach both natural and artificial family planning methods without bias. - Address myths (e.g., 'a woman cannot get pregnant during menstruation' — she can, especially with short cycles or long sperm survival). - Recognize that some women are more fertile than average; timing education must be individualized.

Menstrual Variations, Disorders, and Nursing Considerations

The NLE regularly tests the TERMINOLOGY of menstrual disorders, their clinical significance, and the nurse's role in patient education and triage. Understanding what is NORMAL helps nurses identify and respond to ABNORMAL findings. MENSTRUAL DISORDER TERMINOLOGY (BOARD VOCABULARY): 1. AMENORRHEA — Absence of menstruation. - PRIMARY AMENORRHEA: Menstruation has NEVER OCCURRED by age 15 (with normal secondary sex characteristics) or age 13 (without any secondary sex characteristics). Causes: chromosomal abnormalities (Turner syndrome), anatomical defects (imperforate hymen, absent uterus), hypothalamic dysfunction. - SECONDARY AMENORRHEA: Menstruation has previously occurred but has STOPPED for ≥3 months (in previously regular cycles) or ≥6 months (in irregular cycles). Most common cause: PREGNANCY. Other causes: hypothalamic dysfunction (stress, excessive exercise, eating disorders), hyperprolactinemia, thyroid disorders, PCOS, premature ovarian failure. - Nursing action: ALWAYS RULE OUT PREGNANCY FIRST in secondary amenorrhea with a urine or serum beta-hCG. 2. DYSMENORRHEA — Painful menstruation. - PRIMARY DYSMENORRHEA: Painful menses WITHOUT underlying pathology. Caused by excess PROSTAGLANDINS (PGF2α) in the endometrium during the secretory/menstrual phase, causing STRONG UTERINE CONTRACTIONS and ISCHEMIA. Onset within 1–2 years of menarche; typically decreases with age and after childbirth. - SECONDARY DYSMENORRHEA: Painful menses WITH an underlying PATHOLOGICAL CAUSE (e.g., ENDOMETRIOSIS — most common cause of secondary dysmenorrhea; adenomyosis; uterine fibroids; pelvic inflammatory disease). Onset typically after age 25; pain may be progressive and worsening. - Nursing Management of Primary Dysmenorrhea: a. FIRST-LINE PHARMACOLOGIC: NSAIDs — MEFENAMIC ACID (250–500 mg q8h) or IBUPROFEN (400 mg q6–8h), taken WITH FOOD to prevent GI irritation. Start 1–2 days before expected menses or at onset of cramps for best effect (prostaglandin synthesis inhibition). b. NON-PHARMACOLOGIC: LOCAL HEAT APPLICATION (heating pad/warm compress to lower abdomen) — increases blood flow and reduces uterine muscle spasm; EXERCISE (endorphin release); RELAXATION TECHNIQUES. c. REFERRAL: If dysmenorrhea is severe, resistant to NSAIDs, worsening, or begins after age 25 → suspect secondary cause → refer to OB-Gyne. 3. MENORRHAGIA — Abnormally HEAVY or PROLONGED menstrual bleeding (>80 mL or >7 days). Causes: uterine fibroids, adenomyosis, coagulation disorders, thyroid dysfunction, anovulatory cycles. Risk: IRON-DEFICIENCY ANEMIA. 4. METRORRHAGIA — Bleeding BETWEEN periods (intermenstrual bleeding). May be normal (implantation bleeding, ovulatory spotting) or abnormal (cervical polyps, cervical cancer, breakthrough bleeding on OCP, endometrial pathology). POSTCOITAL BLEEDING is a red flag for cervical lesions. 5. OLIGOMENORRHEA — Infrequent, light menses (cycles >35 days but not absent). Often associated with PCOS, thyroid disorders, perimenopause. 6. POLYMENORRHEA — Abnormally FREQUENT periods (cycle length <21 days). 7. MENOMETRORRHAGIA — HEAVY, IRREGULAR bleeding (combination of menorrhagia and metrorrhagia). 8. HYPOMENORRHEA — SCANTY or abnormally LIGHT menstrual flow (may indicate Asherman's syndrome — intrauterine adhesions — or hormonal insufficiency). MENOPAUSE AND PERIMENOPAUSE: - CLIMACTERIC/PERIMENOPAUSE: The 2–8 year transition period leading to menopause. Characterized by irregular cycles, fluctuating oestrogen levels, and VASOMOTOR SYMPTOMS. - MENOPAUSE: Defined as 12 consecutive months WITHOUT a menstrual period; average age ~51 years. Confirmed retrospectively. - PATHOPHYSIOLOGY: Ovarian follicle depletion → oestrogen production falls → FSH and LH rise dramatically (removing negative feedback) → characteristic symptoms. - SYMPTOMS: HOT FLUSHES (most common), night sweats, vaginal dryness and atrophy (genitourinary syndrome of menopause/GSM), mood changes, sleep disturbances, decreased bone density (osteoporosis risk), changes in lipid profile (cardiovascular risk increases). - POSTMENOPAUSAL BLEEDING: Any vaginal bleeding 12+ months after the last menstrual period must be INVESTIGATED to rule out ENDOMETRIAL CANCER (most common cause of postmenopausal bleeding). It is NEVER normal — immediate referral is indicated. NURSING CONSIDERATIONS AND HEALTH EDUCATION: 1. PERINEAL HYGIENE: Teach FRONT-TO-BACK perineal wiping after urination and defecation to prevent fecal contamination of the vaginal vestibule and urethral meatus (reduces risk of UTI and vaginal infection). This is rooted in the anatomical proximity of the vaginal opening, urethral meatus, and anus. 2. MENSTRUAL HYGIENE: Teach proper use, change intervals, and disposal of menstrual products (pads, tampons). Tampons should be changed every 4–8 hours to prevent Toxic Shock Syndrome (TSS). 3. NORMAL CYCLE EDUCATION: Every woman should know her cycle's normal pattern (length, duration, flow, associated symptoms) so she can identify deviations. Provide culturally sensitive menstrual health education. 4. FERTILITY MYTHS: Correct common misconceptions (e.g., pregnancy cannot occur during menstruation — it can; irregular cycles do not mean infertility — evaluation is needed; breastfeeding is not a reliable contraceptive — LACTATIONAL AMENORRHEA METHOD has specific criteria under RA 10354). 5. DYSMENORRHEA SELF-CARE: Heat + NSAIDs + rest; recognize when to seek professional care (fever, severe unilateral pain, pain unresponsive to NSAIDs, progressive worsening = secondary dysmenorrhea signs). 6. ABNORMAL BLEEDING RED FLAGS REQUIRING REFERRAL: - Postcoital bleeding - Postmenopausal bleeding - Sudden severe acute pelvic pain with bleeding (ectopic pregnancy) - Very heavy bleeding with hemodynamic instability (hemorrhage) - Irregular bleeding in women >35 years (endometrial pathology)

This is the OVULATION FORMULA. Always subtract 14 from the TOTAL CYCLE LENGTH (not from 28) to find the ovulation day. The luteal phase is a constant ~14 days regardless of total cycle length. The fertile window would be approximately January 13–19 (5 days before through 1 day after ovulation).

The calendar (rhythm) method formula: First fertile day = shortest cycle minus 18; Last fertile day = longest cycle minus 11. Abstinence or barrier contraception should be used during Days 8–19. This window accounts for the variability in ovulation day across different cycle lengths and the lifespan of sperm (up to 5 days) and ovum (~24 hours).

The true (obstetric) conjugate is the shortest AP diameter of the pelvic inlet. It CANNOT be measured directly; it is estimated by subtracting 1.5 cm from the measured diagonal conjugate. A true conjugate <10 cm = contracted pelvis = high risk for CPD and likely indicates cesarean section delivery. This measurement is done during the initial prenatal pelvic assessment or early labor triage at the RHU or hospital.

BBT charting produces a BIPHASIC pattern: LOW temperatures in the follicular phase, a brief DIP at ovulation, then SUSTAINED ELEVATION in the luteal phase. The key limitation of the BBT method is that it only confirms PAST ovulation — it does NOT predict ovulation in advance. For contraceptive use, the POST-OVULATORY INFERTILE PHASE begins after 3 consecutive high temperature readings (3 days past the thermal shift).

With the wife having regular confirmed ovulatory cycles, the male factor is the identified problem. The couple has met the clinical definition of infertility (>12 months of regular unprotected intercourse). The nurse should: (1) Provide non-judgmental counseling; (2) Refer to a urologist or andrologist; (3) Advise lifestyle modifications (avoid heat exposure to scrotum, quit smoking/alcohol, maintain healthy weight); (4) Explain that spermatogenesis takes ~74 days, so lifestyle changes take at least 3 months to show effect on semen quality.

Prostaglandins (PGF2α) released during endometrial breakdown cause strong uterine contractions and ischemia, producing cramping pain. NSAIDs inhibit prostaglandin synthesis and are the FIRST-LINE pharmacologic treatment. Heat is the most effective non-pharmacologic intervention. The nurse documents using NANDA nursing diagnosis: ACUTE PAIN related to increased prostaglandin activity as evidenced by patient's pain rating of 9/10.